FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Acella Pharmaceuticals Phenytoin Sodium Injection Recall

Phenytoin Sodium Injection, USP, 250 mg/5 mL

Acella Pharmaceuticals, LLC · Alpharetta, GA

Risk level
Class III
Reported by FDA
Nov 30, 2022
Recall ID
D-0070-2023
Check your lot numberHow we source this data

Summary

Acella Pharmaceuticals recalled Phenytoin Sodium Injection starting Nov 14, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0070-2023 on Nov 30, 2022. Reason: Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode. Status: Terminated.

Why it was recalled

Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.

Product description

Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005

Lot numbers, UPCs & expiration codes

Lot: E026A001 Exp. 06/2023

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0070-2023
Classification
Class III
Status
Terminated
Recall initiated
Nov 14, 2022
FDA report date
Nov 30, 2022
Quantity
637 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Acella Pharmaceuticals, LLC

Original FDA data

Every field from FDA enforcement report D-0070-2023, exactly as published.

Show all FDA fields
City
Alpharetta
State
GA
Status
Terminated
Country
United States
Event ID
91149
Address
1880 Mcfarland Pkwy Ste 110
Code information
Lot: E026A001 Exp. 06/2023
Postal code
30005-1795
Report date
Nov 30, 2022
Product type
Drugs
Recall number
D-0070-2023
Classification
Class III
Recalling firm
Acella Pharmaceuticals, LLC
Product quantity
637 cartons
Termination date
Aug 21, 2024
Reason for recall
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
Distribution pattern
Nationwide in the USA.
Recall initiation date
Nov 14, 2022
Initial firm notification
Letter
Center classification date
Nov 23, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0070-2023, published Nov 30, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls